Cybin is trading at $11.20, down 5.08% during the October 12 session, with no clear company-specific or broad-market catalyst identified. - No October 12 company announcement clearly explained the decline; the latest identified company news was an October 8 notice of an October 21 investor presentation. - Investors are watching for HLP003 Phase 3 results expected in Q4, but available reporting does not link the upcoming catalyst to the decline. - Major indexes were mixed, without a broad same-direction market move that clearly explains the decline.